ARVO Scientific Presence

28 April - 2 May 2019 | Vancouver, BC


We're excited to attend and present the following posters at The Association for Research in Vision and Ophthalmology (ARVO) this year:
      8-9:45 a.m. on 28 April | West Exhibit Hall  

  • #A0307: Chronic Nonclinical Ocular Toxicity Study of KSI-301 Demonstrates Tolerability after Intravitreal Administration in Cynomolgus Monkeys | Zachary Antonio, Frances Clemo, Leah Quarberg, Alok Sharma
  • #AO595: Functional and Ultrastructural Assessment of Novel OCT Findings in the Cynomolgus Monkey | William Meier
     3-4:45 p.m. on 28 April | West Exhibit Hall  

  • #AO356: Performance of a Novel OCT Segmentation Method for Determining Lesion Volume in the Assessment of a Nonhuman Primate Model of Choroidal Neovascularization | Brian Christian
     8-9:45 a.m. on 2 May | West Exhibit Hall  

  • #AO474: Normative Values for Multifocal ERGs Recorded from Cynomolgus Macaques in a Nonclinical Setting | Ewa Budzyinski, Brian Christian, Jackie Miller

Want to chat with us about your ocular projects at ARVO?

Feel free to reach out to your Covance contact or email us to setup a time to connect during the conference.
Booth #1348

Preclinical and Clinical Ocular Capabilities

The preclinical and clinical ocular teams at Covance have supported more than 10+ globally approved and marketed therapies.

Preclinical: Covance continues to enjoy a strong collaboration with OSOD (Ocular Services on Demand) for preclinical toxicology, ocular DM/PK, and efficacy studies. OSOD is located in Madison, WI, and provides a unique opportunity for OSOD scientists to act as the "ophthalmologist on call" for preclinical studies.

Clinical and Post-Market Studies: In 2017 Covance acquired Chiltern, a company who had significant experience in ocular clinical trials. In the last five years, they have supported more than 80+ ophthalmology studies, evenly split between anterior and posterior with indications in common and rare disease areas. Combining strong global site relationships with regional cultural practices help to facilitate a smooth and timely study set-up and execution. 

Today, Covance, through collaboration with our friends at OSOD, is able to offer an end-to-end ocular development solution.